Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study

by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,

Updated on: July 10,2024 0

Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study

by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,

Updated on:July 10,2024 0

What causes breast cancer?

by Annika Lund,Karolinska InstitutetMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumor beyond the lymph node. Credit: Nephron/WikipediaThere is a lot

Updated on: March 30,2024 0

What causes breast cancer?

by Annika Lund,Karolinska InstitutetMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumor beyond the lymph node. Credit: Nephron/WikipediaThere is a lot

Updated on:March 30,2024 0

Rhombic lip implicated in origins of high-risk medulloblastoma

bySt. Jude Children's Research HospitalTranscriptional atlas of the human fetal cerebellum. (a) Schematic summary of the molecular datasets used to interconnect mouse and human cerebellar pr

Updated on: December 28,2023 9

Rhombic lip implicated in origins of high-risk medulloblastoma

bySt. Jude Children's Research HospitalTranscriptional atlas of the human fetal cerebellum. (a) Schematic summary of the molecular datasets used to interconnect mouse and human cerebellar pr

Updated on:December 28,2023 9

Trial finds that adagrasib demonstrates durable clinical activity in patients with KRAS-G12C mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe oral, selective KRAS G12C inhibitor KRAS-G12C inhibitor adagrasib demonstrated durable clinical activity,

Updated on: January 04,2024 8

Trial finds that adagrasib demonstrates durable clinical activity in patients with KRAS-G12C mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe oral, selective KRAS G12C inhibitor KRAS-G12C inhibitor adagrasib demonstrated durable clinical activity,

Updated on:January 04,2024 8

Pediatric brain cancer is rare. A doctor explains why some kids are more vulnerable than others

by Wendy RudermanCredit: Unsplash/CC0 Public DomainThe odds that a doctor will diagnose your child with pediatric cancer are slim, and the chances of a brain cancer diagnosis are even smaller.Each yea

Updated on: January 11,2024 15

Pediatric brain cancer is rare. A doctor explains why some kids are more vulnerable than others

by Wendy RudermanCredit: Unsplash/CC0 Public DomainThe odds that a doctor will diagnose your child with pediatric cancer are slim, and the chances of a brain cancer diagnosis are even smaller.Each yea

Updated on:January 11,2024 15

Does ejaculating often reduce your risk of prostate cancer?

by Daniel Kelly,The ConversationCredit: Pixabay/CC0 Public DomainIn terms of men's health issues, prostate cancer features high on the agenda. It's thesecond most diagnosed cancer&

Updated on: April 28,2024 0

Does ejaculating often reduce your risk of prostate cancer?

by Daniel Kelly,The ConversationCredit: Pixabay/CC0 Public DomainIn terms of men's health issues, prostate cancer features high on the agenda. It's thesecond most diagnosed cancer&

Updated on:April 28,2024 0

Combining cholesterol-lowering statins with existing cancer drug shows potent effect against breast cancer subtype

by Katie Brace,Beth Israel Deaconess Medical CenterTN/ER-low PDOs are sensitive to combination AZD5363 and pitavastatin. A panel of breast cancer PDOs were treated with DMSO, 1 µM AZD5363, 5 µM

Updated on: August 26,2024 0

Combining cholesterol-lowering statins with existing cancer drug shows potent effect against breast cancer subtype

by Katie Brace,Beth Israel Deaconess Medical CenterTN/ER-low PDOs are sensitive to combination AZD5363 and pitavastatin. A panel of breast cancer PDOs were treated with DMSO, 1 µM AZD5363, 5 µM

Updated on:August 26,2024 0

Anti-diabetic drugs could lower risk of primary and secondary brain cancer

by University of BristolCredit: CC0 Public DomainDiabetic patients who take anti-diabetic drugs—known as glitazones—long term had a lower risk of primary and secondary brain cancer compared with

Updated on: April 07,2024 16

Anti-diabetic drugs could lower risk of primary and secondary brain cancer

by University of BristolCredit: CC0 Public DomainDiabetic patients who take anti-diabetic drugs—known as glitazones—long term had a lower risk of primary and secondary brain cancer compared with

Updated on:April 07,2024 16

What you need to know after a breast cancer diagnosis

by Robin FosterBreast cancer strikes 1 in 8 women in the United States, but being diagnosed with the disease can still make you feel alone.To cope with such devastating news, breast cancer surgeons fr

Updated on: October 24,2024 0

What you need to know after a breast cancer diagnosis

by Robin FosterBreast cancer strikes 1 in 8 women in the United States, but being diagnosed with the disease can still make you feel alone.To cope with such devastating news, breast cancer surgeons fr

Updated on:October 24,2024 0

Scurvy is largely a historical disease but there are signs it's making a comeback

by Lauren Ball,The ConversationCredit:Matilda Wormwood/PexelsScurvy is often considered a historical ailment, conjuring images of sailors on long sea voyages suffering from a lack of fresh

Updated on: November 13,2024 0

Scurvy is largely a historical disease but there are signs it's making a comeback

by Lauren Ball,The ConversationCredit:Matilda Wormwood/PexelsScurvy is often considered a historical ailment, conjuring images of sailors on long sea voyages suffering from a lack of fresh

Updated on:November 13,2024 0

Thousands of cancer patients to trial personalised vaccines in England | BBC News

Updated on: August 28,2024 0

Thousands of cancer patients to trial personalised vaccines in England | BBC News

Updated on:August 28,2024 0

Study suggests the possibility of combination therapy of SORA and FGF21 in hepatocellular carcinoma

by Higher Education PressFGF21 combined with SORA promotes apoptosis and inhibits proliferation of 7721‐Smad3 cells under anaerobic conditions. Credit: Ting Zhang, Huiling Shi, Shihui Zhang, Qin Zhu,

Updated on: May 16,2024 7

Study suggests the possibility of combination therapy of SORA and FGF21 in hepatocellular carcinoma

by Higher Education PressFGF21 combined with SORA promotes apoptosis and inhibits proliferation of 7721‐Smad3 cells under anaerobic conditions. Credit: Ting Zhang, Huiling Shi, Shihui Zhang, Qin Zhu,

Updated on:May 16,2024 7